The title compound, C 17 H 12 ClN 5 S, has been synthesized as a potent anticancer agent. The dihedral angle between the thiazole and triazole rings is 85.9 (2) . There are intermolecular N-HÁ Á ÁN and C-HÁ Á ÁCl interactions in the crystal structure.
3-(2-Bromo-5-methoxyphenyl)-5-methyl-1-(4-phenyl-1,3-thiazol-2-yl)-1H-1,2,4-triazole
✍ Scribed by Yathirajan, H. S. ;Vijaya Raj, K. K. ;Narayana, B. ;Sarojini, B. K. ;Bolte, Michael
- Publisher
- International Union of Crystallography
- Year
- 2006
- Tongue
- English
- Weight
- 128 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Single-crystal X-ray study T = 293 K Mean '(C±C) = 0.003 A Ê R factor = 0.040 wR factor = 0.116 Data-to-parameter ratio = 15.4 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.
In the title compound, C 16 H 13 Cl 3 N 6 O 3 S, the substituted triazole ring is bound via a methylene bridge to a chlorothiazole unit. There is evidence for significant electron delocalization in the triazolyl system. Both intra-and intermolecular hydrogen bonds are found in the structure.
In the title compound, C 12 H 9 N 5 OS, molecules are linked into chains along the b axis by N-HÁ Á ÁN hydrogen bonds. The packing is further stabilized by C-HÁ Á Á andinteracions.